-Contributing to Standardization in the Testing of Cancer Lymph Node Metastasis by Shortening Testing Times and Augmenting Processing Capacity- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces the launch of the Gene Amplification Detector RD-200 and the LYNOAMP™CK19 gene-amplification reagent, new products in its system for the rapid detection of cancer lymph […]
Genovis has hired Kevin Cook as Senior Application & Market Area Manager for the subsidiary Genovis Inc. Kevin Cook has 20 years of experience with mass spectrometry from both the pharmaceutical and technology industries. Over the past ten years Kevin has worked with marketing and sales of instruments, consumables and reagents for mass spectrometry, which is a […]
BJS Biotechnologies Ltd and Techcomp signed an exclusive distribution agreement in May 2018. Techcomp will now represent and sell the xxpress® qPCR thermal cycler in China, Hong Kong and Taiwan. Techcomp is engaged in the design, development, manufacture and distribution of analytical instruments, life science equipment and laboratory instruments. Operations are grouped into 2 business […]
License and Commercialization Agreement with Illumina BRISBANE, Calif. — CareDx (NASDAQ:CDNA), today announced that, as reported in its Current Report on Form 8-K filed with the Securities Exchange Commission on May 8, 2018, it entered into a License and Commercialization Agreement with Illumina, Inc., which provides CareDx with worldwide distribution, development and commercialization rights to Illumina’s next generation sequencing (NGS) product line for […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore will refrain from offering “2D” sequencing products through the end […]
ISNES, Belgium — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that it has entered into a Global Sales and Distribution Agreement with Active Motif for a range of Research Use Only (“RUO”) kits, that are based on its proprietary Nucleosomics® technology. Founder and Chairman of Active Motif, Joseph M. Fernandez commented “We are continuously looking for innovative […]
TTP Plc (TTP), a leading independent technology and product development company, and Camena Bioscience, a developer of pioneering technology that profiles small molecules, such as metabolites, nutrients or medicines in liquid samples, announced today that they are collaborating to develop an instrument to monitor the health of cell cultures. The new instrument will be used […]
Los Angeles, CA – CalibreScientific is pleased to announce that it has completed the acquisitions of Protein Ark and BioServUK (together the “Companies“), providers of custom and off-the-shelf proteins, antibodies and other products utilized by the academic life science research and diagnostics communities. The inclusion of BioServUK and Protein Ark allows the group-at-large to offer […]
Offers two modes of detection from a single antibody Fast visible detection of analytes at nanogram level Enhanced chemi-luminescence detection down to picogram level Easy to use with a single incubation Heidelberg, Germany and Cambridge – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method optimised for Western […]
SUNNYVALE, CA ClearLight Diagnostics, LLC (ClearLight), an early stage developer of an automated, next generation tissue processing and 3D imaging/image analysis platform, announced today that Laurie Goodman, PhD, Chief Scientific Officer, has assumed the position of Interim Chief Executive Officer and has been selected as a Board Member. Dr. Goodman will continue in her role as […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
